InnoBooster Allocates CHF 750,000 to Five Early-Stage Startups for Innovative Solutions
The InnoBooster program has selected five startups to receive CHF 750,000 in funding. The startups are focused on AI-driven 3D design tools, medical devices for osteoarthritis and aortic valve diseases, modular endoscopes, and CO₂ conversion to construction materials. The initiative, part of the Gebert Rüf Stiftung, aims to support university students in advancing their research and development efforts, accelerating their market entry.
Theia Market Signal Identification - AI Assisted
The Gebert Rüf Stiftung's InnoBooster program is funding five early-stage startups with CHF 750,000. Nureo is developing generative AI tools to automate 3D design, reducing design time by up to 90%. Eldian Biomed is working on CloudLi, a therapy for osteoarthritis, with over CHF 1.1 million in prior funding.
TightValve aims to create a device for quantifying aortic valve leakage during surgery, addressing reintervention issues. An EPFL spin-off is developing a modular endoscope, enhancing surgical capabilities. DeltaSpark focuses on converting CO₂ into sustainable construction materials, generating clean hydrogen and oxygen in the process.
Comments